PHEZAM

Brand name authorized in: Lithuania

Active ingredients

The drug PHEZAM contains a combination of these active pharmaceutical ingredients (APIs):

1 Piracetam
UNII ZH516LNZ10 - PIRACETAM

Piracetam’s mode of action in cortical myoclonus is as yet unknown. Piracetam exerts its haemorrheological effects on the platelets, red blood cells, and vessel walls by increasing erythrocyte deformability and by decreasing platelet aggregation, erythrocyte adhesion to vessel walls and capillary vasospasm.

Read about Piracetam
2 Cinnarizine
UNII 3DI2E1X18L - CINNARIZINE

Cinnarizine has been shown to be a non-competitive antagonist of the smooth muscle contractions caused by various vasoactive agents including histamine. Cinnarizine also acts on vascular smooth muscle by selectively inhibiting the calcium influx into depolarised cells, thereby reducing the availability of free Ca2+ ions for the induction and maintenance of contraction.

Read about Cinnarizine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Cinnarizine, combinations
N Nervous system → N07 Other nervous system drugs → N07C Antivertigo preparations → N07CA Antivertigo preparations
Discover more medicines within N07CA52

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1010207, 1087146